Cargando…
Novel peptide–dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer
Phage display technology has been demonstrated to be a powerful tool for screening useful ligands that are capable of specifically binding to biomarkers on the surface of tumor cells. The ligands found by this technique, such as peptides, have been successfully applied in the fields of early cancer...
Autores principales: | Liu, Jianfeng, Liu, Jinjian, Chu, Liping, Wang, Yanming, Duan, Yajun, Feng, Lina, Yang, Cuihong, Wang, Ling, Kong, Deling |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025585/ https://www.ncbi.nlm.nih.gov/pubmed/21289982 http://dx.doi.org/10.2147/IJN.S14601 |
Ejemplares similares
-
Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery
por: Liu, Jianfeng, et al.
Publicado: (2013) -
Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors
por: Zhang, Yumin, et al.
Publicado: (2016) -
Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer
por: Zhang, Yumin, et al.
Publicado: (2016) -
Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy
por: Hu, Qing, et al.
Publicado: (2020) -
DNA Condensation by Peptide-Conjugated PAMAM Dendrimers.
Influence of Peptide Charge
por: Dannert, Corinna, et al.
Publicado: (2023)